RAPID MICRO BIOSYSTEMS, INC. (RPID) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
RPID currently has 45.4M outstanding shares. with moderate dilution risk from 9.43M authorized shares representing 20.8% potential dilution. The company has diluted shareholders by 19.67% over the past 2 years through share issuances.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 19, 2026 |
8-K filing: Rapid Micro Biosystems, Inc. entered into an underwriting agreement and a securities purchase agreement to issue and sell shares of common stock and warrants in a public offering and a concurrent registered direct offering. ($0.14M proceeds) |
45M | 9.4M |
| May 15, 2026 |
10-Q filing | 45.4M shares outstanding |
45M | 9.4M |
| Mar 12, 2026 |
10-K filing | 44.7M shares outstanding |
45M | 9.4M |
| Nov 07, 2025 |
10-Q filing | 39.8M shares outstanding |
40M | 9.4M |
| Aug 12, 2025 |
8-K filing: Rapid Micro Biosystems, Inc. issued warrants to purchase up to 179,104 shares of Common Stock at an exercise price of $3.35 per share in connection with a loan agreement. |
39M | 9.4M |
| May 09, 2025 |
10-Q filing | 39.3M shares outstanding |
39M | 9.4M |
| Feb 28, 2025 |
10-K filing | 38.7M shares outstanding |
39M | 9.4M |
| Nov 07, 2024 |
10-Q filing | 37.7M shares outstanding |
38M | 9.4M |
| Aug 02, 2024 |
10-Q filing | 37.6M shares outstanding |
38M | 9.4M |
| May 03, 2024 |
10-Q filing | 37.6M shares outstanding |
38M | 9.4M |
| Mar 01, 2024 |
10-K filing | 37.2M shares outstanding |
37M | 9.4M |
| Dec 15, 2023 |
S-3 filing: The company is filing an S-3 to offer up to $200,000,000 in aggregate principal amount of Class A common stock, preferred stock, debt securities, warrants and/or units, in any combination and also offering Class A common stock through an at-the-market offering. |
42M | 9.4M |
| Nov 03, 2023 |
10-Q filing | 37.1M shares outstanding |
37M | 0 |
| Aug 04, 2023 |
10-Q filing | 37.0M shares outstanding |
37M | 0 |
| May 09, 2023 |
10-Q filing | 36.8M shares outstanding |
37M | 0 |
| Mar 10, 2023 |
10-K filing | 36.6M shares outstanding |
37M | 0 |
| Nov 10, 2022 |
10-Q filing | 36.4M shares outstanding |
36M | 0 |
| Aug 12, 2022 |
10-Q filing | 36.4M shares outstanding |
36M | 0 |
| May 10, 2022 |
10-Q filing | 36.4M shares outstanding |
36M | 0 |
| Mar 24, 2022 |
10-K filing | 34.6M shares outstanding |
35M | 0 |
| Nov 15, 2021 |
10-Q filing | 35.3M shares outstanding |
35M | 0 |
| Aug 27, 2021 |
10-Q filing | 1.0M shares outstanding |
970K | 0 |
| Jul 12, 2021 |
S-1/A filing: An S-1/A filing indicating the total shares of common stock to be outstanding after this offering will be 38,670,611 shares (or 39,660,611 shares if the underwriters exercise their option to purchase additional shares of Class A common stock in full). |
39M | 0 |
| Jun 25, 2021 |
S-1 filing: This S-1 filing describes a warrant to purchase shares of Series C1 Preferred Stock of Rapid Micro Biosystems, Inc., with an exercise price of $1.15 per share and expiring on May 14, 2027. |
N/A | 0 |